When compared with the AKT/NICD model that we have previously established,22 the AKT/Jag1 mouse is more suitable for experimental therapeutics as it can be used to evaluate the potential of Notch inhibitors for the treatment of ICC. The gene discussed is AKT1; the disease is intrahepatic cholangiocarcinoma.